Commonwealth Bank of Australia’s Idexx Laboratories IDXX Stock Holding History

Commonwealth Bank of Australia’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,208	Closed	-$329K	–	460
2019 Q2	$329K	Buy	1,208 +238	+25%	+$58.6K	﹤0.01%	831
2019 Q1	$215K	Buy	970 +70	+8%	+$14.4K	﹤0.01%	860
2018 Q4	$166K	Buy	900 +7	+0.8%	+$1.44K	﹤0.01%	878
2018 Q3	$221K	Hold	893	–	–	﹤0.01%	905
2018 Q2	$192K	Buy	893 +51	+6%	+$10.5K	﹤0.01%	628
2018 Q1	$160K	Sell	842 -124	-13%	-$22.9K	﹤0.01%	593
2017 Q4	$150K	Sell	966 -77	-7%	-$12.1K	﹤0.01%	591
2017 Q3	$161K	Sell	1,043 -533	-34%	-$84.3K	﹤0.01%	609
2017 Q2	$252K	Buy	1,576 +255	+19%	+$41.4K	﹤0.01%	618
2017 Q1	$204K	Buy	1,321 +886	+204%	+$122K	﹤0.01%	615
2016 Q4	$51K	Buy	435 +235	+118%	+$26.8K	﹤0.01%	763
2016 Q3	$23K	Buy	+200	New	+$21.1K	﹤0.01%	815

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Commonwealth Bank of Australia's IDXX Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Idexx Laboratories (IDXX) in Q3 2019, closing a stake of 1,208 shares — an estimated $329K sold.

Commonwealth Bank of Australia first reported a position in IDXX in Q3 2016 and held it in 12 quarters. The position peaked at $329K in Q2 2019. 720 funds tracked by Wall St. Rank hold IDXX as of Q3 2019.

Commonwealth Bank of Australia reported no remaining Idexx Laboratories position as of Q3 2019 after selling out during the quarter.
Commonwealth Bank of Australia sold 1,208 Idexx Laboratories shares in Q3 2019, an estimated $329K.
Commonwealth Bank of Australia first reported a position in Idexx Laboratories in Q3 2016 and held it in 12 quarters.
Commonwealth Bank of Australia's Idexx Laboratories position peaked at $329K in Q2 2019.
720 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.